Samuel Allen Hamood's most recent trade in Definitive Healthcare Corp - Ordinary Shares - Class A was a trade of 189,190 Class A Common Stock done . Disclosure was reported to the exchange on June 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Definitive Healthcare Corp (Class A) | Samuel Allen Hamood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 189,190 | 289,396 | - | 0 | Class A Common Stock | |
| Nuveen Intermediate Duration Quality Municipal Term Fund | Samuel Allen Hamood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2026 | 22,182 | 47,267 | - | 0 | Ordinary Shares | |
| Nuveen Intermediate Duration Quality Municipal Term Fund | Samuel Allen Hamood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2025 | 1,736 | 25,085 | - | 0 | Ordinary Shares | |
| Definitive Healthcare Corp (Class A) | Samuel Allen Hamood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 55,911 | 100,206 | - | 0 | Class A Common Stock | |
| Definitive Healthcare Corp (Class A) | Samuel Allen Hamood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 26,759 | 58,840 | - | 0 | Class A Common Stock | |
| Definitive Healthcare Corp (Class A) | Samuel Allen Hamood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 17,536 | 32,081 | - | 0 | Class A Common Stock | |
| Finch Therapeutics Group Inc | Samuel Allen Hamood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 44,843 | 44,843 | - | - | Stock Option (right to buy) | |
| Definitive Healthcare Corp (Class A) | Samuel Allen Hamood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 14,545 | 51,582 | - | - | Class A Common Stock | |
| Finch Therapeutics Group Inc | Samuel Allen Hamood | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 25,543 | 25,543 | - | - | Stock Option (right to buy) |